Yew Bio-Pharm Group, Inc. announced earnings results for the full year ended December 31, 2018. For the full year, the company announced total revenue was USD 37.596 million compared to USD 40.539 million a year ago. Operating income was USD 718,597 compared to USD 3.324 million a year ago. Net loss was USD 1.322 million compared to net income of USD 3.213 million a year ago. Basic loss per share from continuing operations was USD 0.03 compared to basic earnings per share from continuing operations of USD 0.06 a year ago.